iTechGuides is reader-supported. When you buy through links on our site, we may earn an affiliate commission. As an Amazon Associate I earn from qualifying purchases. Learn more
Short answer: For a small or intracanalicular vestibular schwannoma, stereotactic radiosurgery (SRS) and microsurgery both provide very high tumor control. SRS usually has the stronger record for preserving facial-nerve function, while hearing outcomes are broadly similar in short- and intermediate-term comparisons and can decline gradually after either treatment. Microsurgery is more often chosen when the tumor is large, compresses the brainstem, causes substantial mass effect, or must be reduced immediately. The right choice depends on tumor size and extension, growth, symptoms, baseline hearing, age, medical fitness, and the treating center’s expertise.
What the two treatments actually do
Stereotactic radiosurgery controls growth rather than removing the tumor
Stereotactic radiosurgery is a precisely targeted radiation treatment. Despite the word “surgery,” it normally involves no incision. A treatment platform delivers a concentrated dose to the vestibular schwannoma, usually in one outpatient session. The goal is to stop further growth; the mass is not physically taken out during treatment.
After SRS, the tumor may remain visible on MRI for years. It can shrink slowly, remain stable, or enlarge temporarily because of treatment-related swelling. That is why a single scan soon after treatment cannot by itself prove success or failure. Long-term MRI surveillance is part of the treatment pathway.
Free tools Windows power users keep installed
One-click scans. No signup required.
Microsurgery removes or debulks the lesion
Microsurgical resection uses a craniotomy and direct tumor removal. Depending on the anatomy and the surgeon’s priorities, the operation may aim for complete removal or a deliberate subtotal debulking that protects the facial nerve, hearing structures, or brainstem. The immediate benefit is physical reduction of the tumor and, when complete removal is feasible, removal of the mass causing compression.
#1 Best Overall
- Read Before You Buy — No Video Output: These adapters support charging and USB 2.0 data transfer, but cannot transmit video signals. Except for standard USB webcams (which use USB data only), they are not compatible with HDMI/DisplayPort cables, video-capable USB-C hubs, or docking stations with video output.
- Convert USB-A Ports to USB-C: Designed to connect USB-C earphones, cables, flash drives, card readers, and other USB-C accessories to standard USB-A ports. Plug-and-play with no drivers or software required.
- Aluminum Alloy Housing: Built with a sturdy aluminum alloy shell that aids in heat dissipation and protects against daily wear and scratches. Designed to maintain a stable and secure connection.
- Compact & Travel-Friendly: The ultra-compact design allows the adapter to stay plugged into your device without blocking adjacent ports or adding bulk, reducing wear and tear on your original USB ports.
- 12-Month Warranty: Backed by a 12-month manufacturer warranty for peace of mind. Designed to meet strict quality control standards for reliable everyday performance.
Unlike SRS, microsurgery exposes the patient to anesthesia and operative risks. It also does not guarantee that every tumor cell can be removed safely; residual or recurrent tumor can require MRI monitoring and, occasionally, additional treatment.
How effective are SRS and microsurgery for small tumors?
The best comparative evidence for small lesions comes from observational studies rather than a randomized trial. An International Stereotactic Radiosurgery Society (ISRS) meta-analysis of 40 studies involving 2,371 patients with intracanalicular tumors found 96% tumor control after SRS. The need for additional treatment was 1% after SRS and 2% after microsurgery in the pooled data. These are averages across different centers and definitions, not guarantees for an individual patient.
The same analysis found nearly identical pooled hearing-preservation rates in this setting: 67% with SRS and 68% with microsurgery. The clearest difference was facial-nerve function. Persistent facial-nerve deficit occurred in 0.1% of the pooled SRS series versus 10% of the pooled microsurgical series.
Quick wins for a faster PC:
Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →Clear out junk files and repair common Windows errorsFree Scan →Scan for outdated or missing drivers - takes under a minuteDriver Scan →A separate meta-analysis estimated tumor control of 94% after microsurgery and 80% after SRS for small-to-medium tumors. Its studies were heterogeneous and nonrandomized, so the apparently higher surgical control rate may partly reflect which patients were selected for each treatment, how control was defined, and how long patients were followed. It should not be interpreted as a universal prediction that surgery is more effective.
Comparison at a glance
| Question | Stereotactic radiosurgery | Microsurgical resection |
|---|---|---|
| What happens to the tumor? | Focused radiation controls growth; the tumor is not immediately removed. | Craniotomy with microsurgical removal or debulking gives immediate physical reduction. |
| Most established size context | Commonly used for small-to-medium tumors. The European Association of Neuro-Oncology (EANO) describes established use for tumors under about 3 cm, with selected use in larger lesions. | Frequently selected for large tumors, symptomatic compression, brainstem displacement, or a need for immediate decompression. |
| Tumor control | 96% pooled control for intracanalicular tumors; 89% overall in a review of large-tumor SRS series. | High control in modern series; one heterogeneous meta-analysis estimated 94% for small-to-medium tumors. |
| Hearing preservation | 67% in pooled intracanalicular data. Among patients with serviceable hearing before treatment, the CNS update estimated 71% at 2 years, 59% at 5 years, and 38% at 10 years. | 68% in pooled intracanalicular data. The corresponding CNS estimates were 48% at 2 years, 40% at 5 years, and 32% at 10 years. |
| Facial-nerve outcome | Persistent deficit was 0.1% in pooled intracanalicular SRS studies. Across large-tumor SRS series, facial palsy was 1.3% overall. | Persistent deficit was 10% in pooled intracanalicular microsurgical studies. One comparative meta-analysis reported facial-symmetry loss in 14.3% of surgical patients. |
| Main trade-offs | Delayed swelling, temporary symptoms, radiation-related cranial-nerve effects, and possible salvage surgery if growth continues. | Operative and anesthesia risks, including cerebrospinal-fluid leak, infection, stroke, facial or hearing injury, and balance problems. |
| Follow-up | Serial MRI and audiometry are required because shrinkage is delayed and temporary enlargement can occur. | Postoperative MRI and functional follow-up are required to detect residual or recurrent tumor and track hearing, facial movement, and balance. |
Hearing preservation is a time-dependent outcome
“Hearing preserved” can mean different things in different studies, and a favorable early result does not ensure usable hearing a decade later. The Congress of Neurological Surgeons (CNS) hearing update gives time-specific estimates for people who had serviceable hearing before treatment:
Rank #2
- 5-in-1 USB-C Hub: Experience comprehensive connectivity featuring a Power Delivery input, two USB-A 2.0 ports, a USB-A 3.0 port, and an HDMI port. (Note: The USB-C power delivery input port is only for connecting an external wall charger to power your laptop and cannot power peripheral devices.)
- 90W Pass-Through Charging: Achieve optimal charging with 90W pass-through power to your laptop, supported by a total input of 100W, with the hub reserving 10W for operational efficiency. (Note: Wall charger not included.)
- Quick Data Transfers: Accelerate your productivity with rapid data transfers using a high-speed 5Gbps USB 3.0 port and two 480Mbps USB 2.0 ports.
- 4K HDMI Display: Enhance your visual experience with a hub capable of delivering 4K resolution at 30Hz in both mirror and extend modes. Please note that this hub is compatible with MacBook (macOS 12 and newer), Windows 10 and 11, ChromeOS, and laptops equipped with DP Alt Mode and Power Delivery. Note: This device is not compatible with Linux.
- What You Get: Anker USB-C Hub (5-in-1, 4K HDMI), welcome guide, 18-month warranty, and our friendly customer service.
- After radiosurgery: serviceable hearing in 71% at 2 years, 59% at 5 years, and 38% at 10 years.
- After microsurgery: serviceable hearing in 48% at 2 years, 40% at 5 years, and 32% at 10 years.
These figures describe groups, not a personal forecast. Baseline audiogram quality, tumor size and extension, the radiation dose received by the cochlea, the prescribed marginal dose, age, and other anatomic factors all change the odds. Hearing can deteriorate gradually after either modality, even when the tumor remains controlled.
For an individual consultation, ask the team to state exactly what hearing category it uses, how your current audiogram fits that category, and whether the estimate applies to your tumor’s location and volume. A statement that “hearing preservation is possible” is incomplete without a time horizon and a definition of usable hearing.
Facial-nerve function: the most consistent comparative advantage for SRS
Facial-nerve function is separate from hearing. A patient can retain hearing but develop facial weakness, or have normal facial movement while hearing declines. In small and intracanalicular tumors, the pooled ISRS data show a major difference in persistent facial-nerve deficit: 0.1% after SRS versus 10% after microsurgery. The EANO guideline summarizes five prospective, nonrandomized studies as showing SRS superior to microsurgery for preserving facial-nerve and hearing function in tumors under 3 cm.
That guideline statement is evidence class II, not randomized proof. Surgical technique, tumor adherence to the nerve, pre-treatment facial function, and the center’s experience can materially alter an individual result. For larger tumors, the large-tumor SRS review reported facial palsy in 1.3% overall and 3.4% among patients without prior surgery, but these were selected, lower-level series and should not be generalized to every large tumor.
When microsurgery is usually favored
Large tumors or brainstem compression
A large vestibular schwannoma that compresses the brainstem or produces substantial mass effect often creates a need for immediate decompression. Microsurgery physically reduces that pressure, which is why it remains a common recommendation in this setting. The decision can involve complete removal, planned subtotal resection, or a staged strategy designed to protect critical nerves.
Rank #3
- Sleek 7-in-1 USB-C Hub: Features an HDMI port, two USB-A 3.0 ports, and a USB-C data port, each providing 5Gbps transfer speeds. It also includes a USB-C PD input port for charging up to 100W and dual SD and TF card slots, all in a compact design.
- Flawless 4K@60Hz Video with HDMI: Delivers exceptional clarity and smoothness with its 4K@60Hz HDMI port, making it ideal for high-definition presentations and entertainment. (Note: Only the HDMI port supports video projection; the USB-C port is for data transfer only.)
- Double Up on Efficiency: The two USB-A 3.0 ports and a USB-C port support a fast 5Gbps data rate, significantly boosting your transfer speeds and improving productivity.
- Fast and Reliable 85W Charging: Offers high-capacity, speedy charging for laptops up to 85W, so you spend less time tethered to an outlet and more time being productive.
- What You Get: Anker USB-C Hub (7-in-1), welcome guide, 18-month warranty, and our friendly customer service.
Progressive mass effect or disabling symptoms
Rapid growth, worsening brainstem or cerebellar compression, hydrocephalus, or symptoms that require prompt volume reduction can favor an operation. The CNS surgical guideline emphasizes that the intervention should be matched to the specific lesion and the individual who has it.
Windows Errors? Fix Them Before They Spread
Repair common Windows errors and clear accumulated junk for a smoother, more stable PC - no reinstall needed.Free scan · no reinstallCrashes, No Sound, or Screen Glitches?
Random freezes, missing sound and display glitches usually trace back to one bad driver. Find and replace yours safely.Free scan · under a minuteTrigeminal neuralgia or significant facial pain
Level III CNS guidance indicates that surgery may provide better relief of trigeminal neuralgia than SRS. This does not mean every patient with facial pain needs an operation; it means the symptom should be part of the treatment discussion rather than treated as an afterthought.
When SRS is usually favored
Small or intracanalicular tumors with useful hearing
For a tumor confined largely to the internal auditory canal or measuring under about 3 cm, SRS offers high control without a craniotomy and has the strongest consistent comparative signal for facial-nerve preservation. It is often attractive when the patient wants to avoid operative recovery and accepts the need for long-term imaging.
Patients for whom an operation carries unusual risk
Age, medical fitness, anesthesia risk, anticoagulation issues, or other health factors can shift the balance toward a noninvasive treatment. The choice still requires review of tumor anatomy and the likelihood that delayed swelling or later intervention would create problems.
A preference for control rather than immediate removal
SRS is appropriate only when the patient understands that the tumor remains in place. The objective is durable growth control, not an immediate clear MRI. A person who finds the presence of residual tumor unacceptable may value microsurgical removal more, while another may place greater weight on avoiding an operation.
Rank #4
- Dual Converters, Infinite Potential：Includes 2× USB C male to USB A female adapters and 2× USB A male to USB C female adapters. Perfect for a wide range of uses—tablets with Bluetooth keyboards, expand USB ports on macbook, and more. Two different converters for all your daily needs
- Next-Level 10Gbps & 3A Charging: No more slow 480Mbps, this usb to usb c adapter has a transfer speed of up to 10Gbps, allowing you to do more transferring in less time. This usb adapter fits both USB A and USB C charger, supporting up to 3A fast charging
- Upgraded Exquisite Craftsmanship: With an aluminum alloy housing and metal connector, the usbc to usb adapter is extremely durable and sturdy. Rigorously tested to withstand more than 10,000 times of plugging and unplugging, ensuring long-lasting performance
- Broad Compatible: The usb c to usb adapter widely supports all USB C/ USB A devices like laptops, tablets, cellphones, car chargers, and phone chargers. Such as compatible with MacBook Pro/Air 2023/2022, Thunderbolt 4/3 Devices,Apple MagSafe Watch 9/8/7/SE/Ultra, iPad Pro 2022/2021, Samsung Galaxy S23/S20/S10, and iPhone 17/16/15 Pro. Plug and play
- Please Note: To reach 10Gbps speed, keep the cable under 3.3 ft. For USB A Male to USB C adapters, try flipping the USB C connector. USB C Male to USB A adapters support bidirectional 10Gbps transfer within 3.3 ft
What is known about SRS for large tumors?
Large tumors can sometimes be treated with SRS, but the evidence is weaker and the approach is selective. A review of large-tumor SRS series reported 89% overall tumor control after single-fraction treatment. In patients without prior surgery, control was 93.7%, facial palsy 3.4%, and hearing preservation 40.4%; across all included patients, hearing preservation was 34.2% and facial palsy 1.3%.
Those series were selected and largely lower-level evidence. Some patients still required later surgery because of persistent growth, swelling, or mass effect. Therefore, SRS should not be presented as a universal substitute for microsurgery when a large lesion compresses the brainstem. A skull-base team may instead discuss microsurgery, staged treatment, or a combined approach based on the exact volume and extension.
Risks and recovery trade-offs
SRS-specific issues
- Delayed radiographic response: the tumor may not shrink promptly, and temporary enlargement can mimic progression.
- Swelling and temporary symptoms: treatment-related edema can produce new or worsening symptoms and may require medical management.
- Cranial-nerve effects: radiation-related injury can affect facial, hearing, vestibular, or other nearby nerves.
- Need for salvage treatment: a minority of patients need further treatment if growth continues or symptoms become unacceptable.
- More difficult salvage surgery: the CNS guideline advises that patients who need microsurgery after SRS should be counseled about a greater likelihood of subtotal resection and reduced facial-nerve function.
Microsurgery-specific issues
- Operative and anesthesia complications: possible problems include stroke, infection, and anesthesia-related events.
- Cerebrospinal-fluid leak: a leak can require additional treatment and prolong recovery.
- Facial and hearing injury: manipulating a tumor attached to the facial and vestibulocochlear nerves can cause weakness or hearing loss.
- Balance disturbance: postoperative disequilibrium is possible and may require rehabilitation.
- Residual or recurrent tumor: even after an operation, follow-up MRI is needed and further treatment may occasionally be necessary.
What happens if the tumor grows after radiosurgery?
One enlarging MRI does not automatically mean SRS failed. Temporary post-treatment enlargement can occur, so clinicians interpret the scan in the context of timing, symptoms, contrast pattern, and subsequent imaging. Serial MRI is used to distinguish transient swelling from sustained growth.
If growth is confirmed or mass effect develops, options can include continued observation in selected cases, repeat radiation in carefully chosen situations, or microsurgery. Salvage surgery after SRS can be technically more difficult. The CNS surgical guideline specifically recommends counseling about increased chances of subtotal removal and poorer facial-nerve function compared with an operation performed without prior SRS.
Ask before treatment what the center’s surveillance schedule is, what scan pattern would trigger concern, and which surgeons would manage salvage treatment if it became necessary. This contingency is part of informed consent, not a prediction that your tumor will recur.
Best Value
- 5-in-1 Connectivity: Equipped with a 4K HDMI port, a 5 Gbps USB-C data port, two 5 Gbps USB-A ports, and a USB C 100W PD-IN port. Note: The USB C 100W PD-IN port supports only charging and does not support data transfer devices such as headphones or speakers.
- Powerful Pass-Through Charging: Supports up to 85W pass-through charging so you can power up your laptop while you use the hub. Note: Pass-through charging requires a charger (not included). Note: To achieve full power for iPad, we recommend using a 45W wall charger.
- Transfer Files in Seconds: Move files to and from your laptop at speeds of up to 5 Gbps via the USB-C and USB-A data ports. Note: The USB C 5Gbps Data port does not support video output.
- HD Display: Connect to the HDMI port to stream or mirror content to an external monitor in resolutions of up to 4K@30Hz. Note: The USB-C ports do not support video output.
- What You Get: Anker 332 USB-C Hub (5-in-1), welcome guide, our worry-free 18-month warranty, and friendly customer service.
Follow-up after either treatment
Neither pathway ends on the treatment date. SRS requires serial MRI because control is defined radiographically over time and because transient enlargement can occur. Audiometry tracks gradual hearing change and helps distinguish tumor control from functional decline. Microsurgery also requires postoperative MRI to assess the extent of removal and detect residual or recurrent tumor, along with examinations of facial movement, hearing, balance, and other symptoms.
The exact schedule is individualized by the treating team. Bring prior scans and audiograms to each visit so that small changes can be compared consistently rather than judged from a single report.
A practical decision framework
- Define the anatomy. Confirm the tumor’s largest dimension, whether it is intracanalicular or extends into the cerebellopontine angle, and whether it contacts or compresses the brainstem.
- Document baseline function. Use a formal audiogram and facial-nerve examination. Record tinnitus, dizziness, imbalance, trigeminal symptoms, and other neurologic findings separately from hearing.
- Establish the behavior. Compare serial MRI scans when available to determine whether the lesion is stable or growing. A single scan cannot establish a growth rate.
- Match urgency to anatomy. Brainstem compression, major mass effect, hydrocephalus, or rapidly progressive symptoms often make immediate surgical reduction more important than delayed radiation control.
- Compare the outcomes that matter most to you. Discuss facial movement, hearing at 2, 5, and 10 years, balance, tinnitus, recovery time, and the possibility of additional treatment—not just tumor-control percentages.
- Account for center expertise. Ask for the team’s experience with your tumor size and extension, its own complication definitions, and how it handles salvage surgery or rehabilitation.
- Make the contingency explicit. Before SRS, understand the MRI plan and what would happen if the tumor enlarged. Before microsurgery, understand the planned extent of resection and how residual tumor would be monitored.
How to interpret the published percentages
Most comparative evidence is retrospective or otherwise nonrandomized. Patients selected for SRS may differ systematically from those selected for microsurgery in age, tumor size, anatomy, hearing, symptoms, and medical risk. Studies also use different definitions of “tumor control,” “serviceable hearing,” facial-nerve deficit, and follow-up duration.
Do these 3 things before closing this tab:
1Clear out junk files and repair common Windows errors2Fix the driver behind crashes, sound loss and screen glitches3Repair Windows errors before they cause bigger problemsThere is no single randomized trial that settles SRS versus microsurgery for every tumor size and patient profile. Tinnitus, dizziness, trigeminal symptoms, quality of life, and salvage outcomes are measured less consistently than tumor control, hearing, and facial-nerve function. Percentages therefore help frame a consultation but cannot replace an individualized estimate from a skull-base team.
Questions to take to a skull-base consultation
- What are the tumor’s exact dimensions, extension, and evidence of growth?
- Is there brainstem compression, hydrocephalus, or another reason that immediate decompression is important?
- How is my current hearing classified, and what are your center’s hearing estimates at 2, 5, and 10 years for patients like me?
- What facial-nerve outcome do you expect for this tumor, and how do you define a deficit?
- If you recommend SRS, how will you distinguish temporary enlargement from true treatment failure?
- If I need surgery after SRS, how might prior radiation change the extent of removal or facial-nerve risk?
- If you recommend microsurgery, is the goal complete removal or planned debulking, and what would happen to residual tumor?
- How often will MRI and audiometry be performed, and who will coordinate rehabilitation if hearing or balance declines?
Bottom line for the choice
For small or intracanalicular vestibular schwannomas, SRS and microsurgery both have high tumor-control rates. SRS generally offers better facial-nerve preservation, while hearing can decline over years after either treatment and is broadly similar in many short- and intermediate-term comparisons. Microsurgery is usually more compelling when a large tumor compresses the brainstem, causes substantial mass effect, produces symptoms that need immediate relief, or when physical removal is the patient’s priority. Because anatomy, baseline function, growth, health, and local expertise change the balance, the safest choice is the one made with a multidisciplinary skull-base team using your own MRI and audiogram rather than a headline percentage.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
